{"data":{"id":"us-nv/nrs-422.4026","jurisdiction":"us-nv","citation":"NRS 422.4026","heading":"Coverage of certain supplements for treating sickle cell disease and its variants: Adoption of list by regulation; periodic review of list.","body":"1. The Authority, upon the recommendation of the Board, shall prescribe by regulation a list of nonprescription supplements essential for treating sickle cell disease and its variants that must be covered by Medicaid for recipients who have sickle cell disease and its variants.\n2. The Board shall review the list of supplements prescribed pursuant to subsection 1 at least biennially to determine whether to recommend adding or removing any supplements from the list and report those recommendations to the Authority.","path":["TITLE 38 — PUBLIC ASSISTANCE","CHAPTER 422 - MEDICAID AND OTHER HEALTH CARE PROGRAMS","PRESCRIPTION DRUGS"],"source_url":"https://www.leg.state.nv.us/NRS/NRS-422.html#NRS422Sec4026","current_through":"2025 session (NRS as revised 2026-08-25)","vintage":"","retrieved_at":"2026-09-03T05:51:39Z","sha256":"f1b62b8bba5decc4a4a48c1c3e44d61ff2b671252062061ac9b272d87aca44b4","source_id":"us-nv","stale":true,"prev":"us-nv/nrs-422.4025--2","next":"us-nv/nrs-422.403"},"notice":"GroundRules: Original legal text. Not legal advice."}